Medical Care
Global Crohn’s Disease Diagnostic and Therapeutic Market Research Report 2025
- Sep 18, 25
- ID: 507556
- Pages: 72
- Figures: 74
- Views: 7
This report aims to provide a comprehensive presentation of the global market for Crohn’s Disease Diagnostic and Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn’s Disease Diagnostic and Therapeutic.
The Crohn’s Disease Diagnostic and Therapeutic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Crohn’s Disease Diagnostic and Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crohn’s Disease Diagnostic and Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Celgene
Genetech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda Pharmaceutical
Segment by Type
Diagnostics
Treatment
Segment by Application
Hospital
Medical Research Institute
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crohn’s Disease Diagnostic and Therapeutic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Crohn’s Disease Diagnostic and Therapeutic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Crohn’s Disease Diagnostic and Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crohn’s Disease Diagnostic and Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Celgene
Genetech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda Pharmaceutical
Segment by Type
Diagnostics
Treatment
Segment by Application
Hospital
Medical Research Institute
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crohn’s Disease Diagnostic and Therapeutic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostics
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Medical Research Institute
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Perspective (2020-2031)
2.2 Global Crohn’s Disease Diagnostic and Therapeutic Growth Trends by Region
2.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Region (2020-2025)
2.2.3 Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Region (2026-2031)
2.3 Crohn’s Disease Diagnostic and Therapeutic Market Dynamics
2.3.1 Crohn’s Disease Diagnostic and Therapeutic Industry Trends
2.3.2 Crohn’s Disease Diagnostic and Therapeutic Market Drivers
2.3.3 Crohn’s Disease Diagnostic and Therapeutic Market Challenges
2.3.4 Crohn’s Disease Diagnostic and Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue
3.1.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue (2020-2025)
3.1.2 Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Players (2020-2025)
3.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Crohn’s Disease Diagnostic and Therapeutic Revenue
3.4 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio
3.4.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2024
3.5 Global Key Players of Crohn’s Disease Diagnostic and Therapeutic Head office and Area Served
3.6 Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Product and Application
3.7 Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Diagnostic and Therapeutic Breakdown Data by Type
4.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Type (2020-2025)
4.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2026-2031)
5 Crohn’s Disease Diagnostic and Therapeutic Breakdown Data by Application
5.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Application (2020-2025)
5.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size (2020-2031)
6.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025)
6.4 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size (2020-2031)
7.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025)
7.4 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size (2020-2031)
8.2 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2020-2025)
8.4 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size (2020-2031)
9.2 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025)
9.4 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size (2020-2031)
10.2 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025)
10.4 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Crohn’s Disease Diagnostic and Therapeutic Introduction
11.1.4 Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.1.5 Abbvie Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Crohn’s Disease Diagnostic and Therapeutic Introduction
11.2.4 Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.2.5 Celgene Recent Development
11.3 Genetech
11.3.1 Genetech Company Details
11.3.2 Genetech Business Overview
11.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Introduction
11.3.4 Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.3.5 Genetech Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Introduction
11.4.4 Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Introduction
11.5.4 Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Prometheus Laboratories
11.6.1 Prometheus Laboratories Company Details
11.6.2 Prometheus Laboratories Business Overview
11.6.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Introduction
11.6.4 Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.6.5 Prometheus Laboratories Recent Development
11.7 Salix Pharmaceuticals
11.7.1 Salix Pharmaceuticals Company Details
11.7.2 Salix Pharmaceuticals Business Overview
11.7.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Introduction
11.7.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.7.5 Salix Pharmaceuticals Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Introduction
11.8.4 Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.8.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostics
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Medical Research Institute
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Perspective (2020-2031)
2.2 Global Crohn’s Disease Diagnostic and Therapeutic Growth Trends by Region
2.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Region (2020-2025)
2.2.3 Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Region (2026-2031)
2.3 Crohn’s Disease Diagnostic and Therapeutic Market Dynamics
2.3.1 Crohn’s Disease Diagnostic and Therapeutic Industry Trends
2.3.2 Crohn’s Disease Diagnostic and Therapeutic Market Drivers
2.3.3 Crohn’s Disease Diagnostic and Therapeutic Market Challenges
2.3.4 Crohn’s Disease Diagnostic and Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue
3.1.1 Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Revenue (2020-2025)
3.1.2 Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Players (2020-2025)
3.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Crohn’s Disease Diagnostic and Therapeutic Revenue
3.4 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio
3.4.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2024
3.5 Global Key Players of Crohn’s Disease Diagnostic and Therapeutic Head office and Area Served
3.6 Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Product and Application
3.7 Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Diagnostic and Therapeutic Breakdown Data by Type
4.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Type (2020-2025)
4.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2026-2031)
5 Crohn’s Disease Diagnostic and Therapeutic Breakdown Data by Application
5.1 Global Crohn’s Disease Diagnostic and Therapeutic Historic Market Size by Application (2020-2025)
5.2 Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Crohn’s Disease Diagnostic and Therapeutic Market Size (2020-2031)
6.2 North America Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025)
6.4 North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size (2020-2031)
7.2 Europe Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025)
7.4 Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size (2020-2031)
8.2 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2020-2025)
8.4 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size (2020-2031)
9.2 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025)
9.4 Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size (2020-2031)
10.2 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025)
10.4 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Crohn’s Disease Diagnostic and Therapeutic Introduction
11.1.4 Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.1.5 Abbvie Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Crohn’s Disease Diagnostic and Therapeutic Introduction
11.2.4 Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.2.5 Celgene Recent Development
11.3 Genetech
11.3.1 Genetech Company Details
11.3.2 Genetech Business Overview
11.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Introduction
11.3.4 Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.3.5 Genetech Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Introduction
11.4.4 Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Introduction
11.5.4 Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Prometheus Laboratories
11.6.1 Prometheus Laboratories Company Details
11.6.2 Prometheus Laboratories Business Overview
11.6.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Introduction
11.6.4 Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.6.5 Prometheus Laboratories Recent Development
11.7 Salix Pharmaceuticals
11.7.1 Salix Pharmaceuticals Company Details
11.7.2 Salix Pharmaceuticals Business Overview
11.7.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Introduction
11.7.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.7.5 Salix Pharmaceuticals Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Introduction
11.8.4 Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
11.8.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnostics
Table 3. Key Players of Treatment
Table 4. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2020-2025)
Table 8. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2026-2031)
Table 10. Crohn’s Disease Diagnostic and Therapeutic Market Trends
Table 11. Crohn’s Disease Diagnostic and Therapeutic Market Drivers
Table 12. Crohn’s Disease Diagnostic and Therapeutic Market Challenges
Table 13. Crohn’s Disease Diagnostic and Therapeutic Market Restraints
Table 14. Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players (2020-2025)
Table 16. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2024)
Table 17. Ranking of Global Top Crohn’s Disease Diagnostic and Therapeutic Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Headquarters and Area Served
Table 20. Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Product and Application
Table 21. Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2020-2025)
Table 25. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2026-2031)
Table 27. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Application (2020-2025)
Table 29. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Application (2026-2031)
Table 31. North America Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbvie Company Details
Table 47. Abbvie Business Overview
Table 48. Abbvie Crohn’s Disease Diagnostic and Therapeutic Product
Table 49. Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 50. Abbvie Recent Development
Table 51. Celgene Company Details
Table 52. Celgene Business Overview
Table 53. Celgene Crohn’s Disease Diagnostic and Therapeutic Product
Table 54. Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 55. Celgene Recent Development
Table 56. Genetech Company Details
Table 57. Genetech Business Overview
Table 58. Genetech Crohn’s Disease Diagnostic and Therapeutic Product
Table 59. Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 60. Genetech Recent Development
Table 61. Johnson & Johnson Company Details
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Product
Table 64. Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Crohn’s Disease Diagnostic and Therapeutic Product
Table 69. Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Prometheus Laboratories Company Details
Table 72. Prometheus Laboratories Business Overview
Table 73. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Product
Table 74. Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 75. Prometheus Laboratories Recent Development
Table 76. Salix Pharmaceuticals Company Details
Table 77. Salix Pharmaceuticals Business Overview
Table 78. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Product
Table 79. Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 80. Salix Pharmaceuticals Recent Development
Table 81. Takeda Pharmaceutical Company Details
Table 82. Takeda Pharmaceutical Business Overview
Table 83. Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Product
Table 84. Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 85. Takeda Pharmaceutical Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Crohn’s Disease Diagnostic and Therapeutic Picture
Figure 2. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Type: 2024 VS 2031
Figure 4. Diagnostics Features
Figure 5. Treatment Features
Figure 6. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Medical Research Institute Case Studies
Figure 10. Other Case Studies
Figure 11. Crohn’s Disease Diagnostic and Therapeutic Report Years Considered
Figure 12. Global Crohn’s Disease Diagnostic and Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Crohn’s Disease Diagnostic and Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Region: 2024 VS 2031
Figure 15. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players in 2024
Figure 16. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2024
Figure 18. North America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2020-2031)
Figure 20. United States Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2020-2031)
Figure 24. Germany Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2020-2031)
Figure 32. China Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2020-2031)
Figure 40. Mexico Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2020-2031)
Figure 44. Turkey Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Abbvie Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 48. Celgene Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 49. Genetech Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 52. Prometheus Laboratories Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 53. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 54. Takeda Pharmaceutical Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnostics
Table 3. Key Players of Treatment
Table 4. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2020-2025)
Table 8. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2026-2031)
Table 10. Crohn’s Disease Diagnostic and Therapeutic Market Trends
Table 11. Crohn’s Disease Diagnostic and Therapeutic Market Drivers
Table 12. Crohn’s Disease Diagnostic and Therapeutic Market Challenges
Table 13. Crohn’s Disease Diagnostic and Therapeutic Market Restraints
Table 14. Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players (2020-2025)
Table 16. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2024)
Table 17. Ranking of Global Top Crohn’s Disease Diagnostic and Therapeutic Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Headquarters and Area Served
Table 20. Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Product and Application
Table 21. Global Key Players of Crohn’s Disease Diagnostic and Therapeutic, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2020-2025)
Table 25. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type (2026-2031)
Table 27. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Application (2020-2025)
Table 29. Global Crohn’s Disease Diagnostic and Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Application (2026-2031)
Table 31. North America Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbvie Company Details
Table 47. Abbvie Business Overview
Table 48. Abbvie Crohn’s Disease Diagnostic and Therapeutic Product
Table 49. Abbvie Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 50. Abbvie Recent Development
Table 51. Celgene Company Details
Table 52. Celgene Business Overview
Table 53. Celgene Crohn’s Disease Diagnostic and Therapeutic Product
Table 54. Celgene Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 55. Celgene Recent Development
Table 56. Genetech Company Details
Table 57. Genetech Business Overview
Table 58. Genetech Crohn’s Disease Diagnostic and Therapeutic Product
Table 59. Genetech Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 60. Genetech Recent Development
Table 61. Johnson & Johnson Company Details
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Product
Table 64. Johnson & Johnson Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Crohn’s Disease Diagnostic and Therapeutic Product
Table 69. Pfizer Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Prometheus Laboratories Company Details
Table 72. Prometheus Laboratories Business Overview
Table 73. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Product
Table 74. Prometheus Laboratories Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 75. Prometheus Laboratories Recent Development
Table 76. Salix Pharmaceuticals Company Details
Table 77. Salix Pharmaceuticals Business Overview
Table 78. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Product
Table 79. Salix Pharmaceuticals Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 80. Salix Pharmaceuticals Recent Development
Table 81. Takeda Pharmaceutical Company Details
Table 82. Takeda Pharmaceutical Business Overview
Table 83. Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Product
Table 84. Takeda Pharmaceutical Revenue in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025) & (US$ Million)
Table 85. Takeda Pharmaceutical Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Crohn’s Disease Diagnostic and Therapeutic Picture
Figure 2. Global Crohn’s Disease Diagnostic and Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Type: 2024 VS 2031
Figure 4. Diagnostics Features
Figure 5. Treatment Features
Figure 6. Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Medical Research Institute Case Studies
Figure 10. Other Case Studies
Figure 11. Crohn’s Disease Diagnostic and Therapeutic Report Years Considered
Figure 12. Global Crohn’s Disease Diagnostic and Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Crohn’s Disease Diagnostic and Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Region: 2024 VS 2031
Figure 15. Global Crohn’s Disease Diagnostic and Therapeutic Market Share by Players in 2024
Figure 16. Global Top Crohn’s Disease Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Diagnostic and Therapeutic as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2024
Figure 18. North America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2020-2031)
Figure 20. United States Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2020-2031)
Figure 24. Germany Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Market Share by Region (2020-2031)
Figure 32. China Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2020-2031)
Figure 40. Mexico Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Market Share by Country (2020-2031)
Figure 44. Turkey Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Crohn’s Disease Diagnostic and Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Abbvie Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 48. Celgene Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 49. Genetech Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 52. Prometheus Laboratories Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 53. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 54. Takeda Pharmaceutical Revenue Growth Rate in Crohn’s Disease Diagnostic and Therapeutic Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232